ISCT establishes working group to tackle regulatory and ethical issues with Expanded Access
The International Society for Cell & Gene Therapy, the global society of clinicians, researchers, regulators, technologists, and industry partners dedicated to the translation of cell and gene therapy (CGT) into safe and effective therapies to improve patients’ lives, today announces it has established a task force to identify and address practical, ethical, and regulatory issues that arise from the use, and potential misuse, of expanded access within the CGT sector.
Read the news published by the International Society for Cell & Gene Therapy on 28 February 2022.
OpenEdition vous propose de citer ce billet de la manière suivante :
lsgilbert (7 novembre 2022). ISCT establishes working group to tackle regulatory and ethical issues with Expanded Access. ELSIBI. Consulté le 19 janvier 2026 à l’adresse https://doi.org/10.58079/o64h





